title: Nail toxicity related to weekly taxanes: an important issue requiring a change in common toxicity criteria grading?
authors.forename: Simon
authors.initials: S
authors.lastname: Spazzapan
authors.forename: Diana
authors.initials: D
authors.lastname: Crivellari
authors.forename: Davide
authors.initials: D
authors.lastname: Lombardi
authors.forename: Cristina
authors.initials: C
authors.lastname: Scuderi
authors.forename: Maria Donatella
authors.initials: MD
authors.lastname: Magri
authors.forename: Andrea
authors.initials: A
authors.lastname: Veronesi
authors.forename: Alessandro
authors.initials: A
authors.lastname: Gatti
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D009260:Nail Diseases / Q000139:chemically induced* / Q000473:pathology; D017239:Paclitaxel / Q000009:adverse effects* / Q000627:therapeutic use; D010858:Pigmentation; D011788:Quality of Life; D012720:Severity of Illness Index
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel